Join the 200th Anniversary Celebration

Original Article

An Association between Collateral Blood Flow and Myocardial Viability in Patients with Recent Myocardial Infarction

Peter J. Sabia, M.D., Eric R. Powers, M.D., Michael Ragosta, M.D., Ian J. Sarembock, M.B., Ch.B., M.D., Lawrence R. Burwell, M.D., and Sanjiv Kaul, M.D.

N Engl J Med 1992; 327:1825-1831December 24, 1992

Abstract
Abstract

Background.

We hypothesized that successful reperfusion of an occluded infarct-related coronary artery even late after acute myocardial infarction would result in improved regional wall motion and that such improvement might be related to the presence of collateral blood flow within the infarct bed.

Methods.

We assessed regional wall motion by two-dimensional echocardiography at base line and one month after angioplasty was attempted in the occluded infarct-related artery in 43 patients who had had a myocardial infarction two days to five weeks earlier. A wall-motion score was assigned to each patient on a five-point scale (from 1 [normal function] to 5 [dyskinesia]). The percentage of the infarct bed perfused by collateral flow was assessed with myocardial contrast echocardiography.

Results.

In the 41 patients who had abnormal wall motion at base line, improvement in function was noted in 25 (78 percent) of the 32 in whom angioplasty was successful, as compared with only 1 (11 percent) of the 9 in whom it was unsuccessful (P<0.001). The percentage of the infarct bed supplied by collateral flow at base line was directly correlated with wall function and inversely correlated with the wall-motion score one month after successful angioplasty (r = -0.64, P<0.001). Among the patients in whom angioplasty was successful, the 23 in whom >50 percent of the infarct bed was supplied by collateral flow had better wall motion (P<0.001) and greater improvement in wall motion at one month (P = 0.004) than the 9 in whom ≤50 percent of the bed was supplied by collateral flow. The degree of improvement in function was not influenced by the length of time between the infarction and the attempted angioplasty.

Conclusions.

The myocardium remains viable for a prolonged period in many patients with acute infarction and an occluded infarct-related artery. Viability appears to be associated with the presence of collateral blood flow within the infarct bed. (N Engl J Med 1992; 327:1825–31.)

Media in This Article

Figure 1Short-Axis View of the Left Ventricle (LV) Obtained by Two-Dimensional Echocardiography in a Patient with an Occluded Right Coronary Artery.
Figure 2Correlation between the Wall-Motion Score One Month after Successful Angioplasty and the Mean (±SEM) Percentage of the Infarct Bed Supplied by Collateral Blood Flow at Base Line.
Article

BESIDES the amount of myocardium at risk, the two main determinants of both infarct size and the amount of viable myocardium after acute coronary occlusion are the duration of occlusion and the extent of collateral blood flow within the occluded vascular bed.1 , 2 Whereas the effect of the duration of coronary occlusion has been extensively studied,3 4 5 6 7 8 previous attempts to assess the importance of collateral vessels in patients with acute myocardial infarction have been limited by the techniques used.9 10 11 12 Coronary angiography, the method most often used to assess collateral blood flow, can identify only vessels greater than 100 μm in diameter,13 whereas most collateral vessels are smaller.14

We hypothesized that collateral blood flow to the infarct zone is common in patients with acute myocardial infarction. Consequently, successful reperfusion of an occluded infarct-related artery in such patients may result in improvement in regional function, and this improvement may be related to the extent of collateral blood flow within the infarct bed. Since adequate residual blood flow would maintain myocardial-cell viability for a prolonged period, we further hypothesized that the recovery of function may not be influenced by the duration of coronary occlusion.

To test these hypotheses, we performed a prospective study of patients with recent myocardial infarction and a totally occluded infarct-related artery. Myocardial contrast echocardiography was used to determine the extent of collateral blood flow to the infarct zone. In this procedure, microbubbles of air were injected directly into the coronary arteries in order to determine the spatial distribution of collateral blood flow within the myocardium.15 16 17 18 19 20 21 We also used this technique to determine the percentage of the left ventricular myocardium supplied by the infarct-related artery. Reperfusion of the infarct-related artery by means of coronary angioplasty was attempted.

Methods

Patients and Protocol

Fifty patients (33 men and 17 women; mean age, 56 years) with recent myocardial infarction (which had occurred two days to five weeks earlier) and a totally occluded infarct-related artery were included in the study. The decision to perform cardiac catheterization in these patients was made by the patients' primary physicians. Only nine (18 percent) of the patients had definite evidence of postinfarction ischemia, as documented by chest pain with associated electrocardiographic changes. Coronary angioplasty was attempted as part of the protocol, which was approved by the Human Investigation Committee at the University of Virginia, and all patients gave written informed consent. No patient with recent myocardial infarction who was found to have an occluded infarct-related artery was excluded from this study during the enrollment period.

Two-dimensional echocardiography was performed at base line. Myocardial contrast echocardiography was performed in the cardiac-catheterization laboratory just before angioplasty was attempted and was repeated after the last balloon inflation in patients in whom angioplasty was successful. Angioplasty was considered successful if anterograde flow was established in the infarct-related artery with a residual stenosis of less than 50 percent, and it was considered unsuccessful if anterograde flow was not reestablished or if reocclusion of an artery that had initially been treated successfully was documented by coronary angiography before hospital discharge. Two-dimensional echocardiography was repeated at one month in all patients, whether or not angioplasty was successful.

Coronary Angiography

The angiogram obtained before angioplasty was attempted was reviewed by two blinded observers who determined the presence or absence of multivessel disease and the extent of visible collateral vessels. Substantial coronary artery disease in arteries other than the infarct-related artery was defined as ≥50 percent narrowing of the luminal diameter of the proximal or middle portion of a major epicardial vessel or its major branches. The extent of perfusion by collateral vessels on angiography was scored as follows: 0, no collateral vessels seen; 1, some collateral vessels seen, with incomplete, delayed filling of the infarct-related artery; 2, well-formed collateral vessels seen, with delayed filling of the infarct-related artery; and 3, abundant collateral vessels seen that filled the infarct-related artery at the same rate as the artery being injected.

Myocardial Contrast Echocardiography

We have previously described the method of assessing collateral blood flow with myocardial contrast echocardiography.21 In brief, 1.5 ml of sonicated diatrizoate sodium—diatrizoate meglumine (Renografin-76, Squibb), which contains 500,000±200,000 microbubbles of air with a mean diameter of 6 μm,22 was injected first into the left main coronary artery and then into the right coronary artery before angioplasty, during simultaneously performed two-dimensional echocardiographic imaging at the mid—papillary-muscle level (short-axis view). We and others have demonstrated this procedure to be safe in humans.23 , 24

In patients in whom angioplasty was successful, microbubbles of air were selectively injected into the opened infarct-related artery to define the perfusion bed supplied by that vessel.21 This region was traced on a clear plastic overlay and expressed as a percentage of the left ventricular myocardium in that short-axis view. The overlay was then superimposed on the contrast echocardiogram obtained before angioplasty during the injection of microbubbles of air into the non—infarct-related artery to determine the percentage of the perfusion bed receiving collateral flow. Regions with any degree of contrast enhancement were distinguished from those with no enhancement. As we have previously reported, regions with less than 15 percent of normal flow do not demonstrate myocardial contrast enhancement after the intracoronary injection of sonicated diatrizoate sodium—diatrizoate meglumine.25

Figure 1Figure 1Short-Axis View of the Left Ventricle (LV) Obtained by Two-Dimensional Echocardiography in a Patient with an Occluded Right Coronary Artery. shows a short-axis echocardiographic view after the injection of microbubbles of air into the left main coronary artery of a patient with an occluded right coronary artery. All regions of the myocardium show contrast enhancement, including that subtended by the occluded right coronary artery. Also shown in Figure 1 is the same view after the occluded right coronary artery was successfully opened by angioplasty (that is, after anterograde flow was established with <50 percent residual stenosis) and microbubbles of air were injected selectively into it to define the perfusion bed of the right coronary artery. It is apparent that before angioplasty, 100 percent of the perfusion bed of the right coronary artery was supplied by collateral blood flow.

In the patients in whom angioplasty was unsuccessful (either no anterograde flow was established during the attempted angioplasty or reocclusion was documented before hospital discharge), the infarct zone was defined as the region with abnormal wall motion. We have previously shown that the size of the perfusion bed of a coronary artery correlates closely with the extent of abnormal wall motion when the artery is occluded.26 The region with abnormal motion was traced on a clear plastic overlay, and its extent was expressed as a percentage of the left ventricular myocardium in the short-axis view. The extent of collateral flow within this region was determined as described above. The interobserver and intraobserver variations in values obtained by our method are small.15

Two-Dimensional Echocardiography

Two-dimensional echocardiography was performed before and one month after angioplasty was attempted. Standard views of the left ventricle were obtained, and wall motion within the infarct bed was graded as follows: 1, normal function; 2, mild hypokinesia; 3, severe hypokinesia; 4, akinesia; and 5, dyskinesia.25 Scoring was carried out by two experienced observers who were blinded to all other information about the patients. The interobserver and intraobserver correlation with this method is good.27 Improvement in regional function after angioplasty was defined as a decrease of at least 1 in the wall-motion score.

Statistical Analysis

All data were expressed as means ±SEM. Data obtained in the same patient before and after angioplasty were compared with either paired Student's t-tests or chi-square tests; comparisons between groups were performed with either unpaired t-tests or Fisher's exact tests.28 Correlations of ordinal data were assessed with Spearman's rank statistic.28 Differences were considered statistically significant at a two-sided P value of <0.05.

Results

Clinical Characteristics

Of the 50 patients initially included in the study, 5 had technically inadequate echocardiographic data at base line because of poor acoustic windows, making it impossible to assess regional function adequately. Two patients did not return for study after angioplasty. Of the remaining 43 patients, 34 (79 percent) underwent successful angioplasty with no clinical evidence of reocclusion, whereas in 9 angioplasty was initially unsuccessful (n = 7) or angioplasty was successful but reocclusion was documented during the hospital stay (n = 2). There were no differences between patients in whom angioplasty was successful and those in whom it was unsuccessful in terms of base-line characteristics (Table 1Table 1Base-Line Clinical Characteristics of Patients with Recent Myocardial Infarction (MI).*).

Regional Wall Motion

In two patients, wall motion within the infarct region was normal at base line; in both, 100 percent of the infarct bed was supplied by collateral flow. Of the remaining 41 patients, wall motion in the infarct region had improved by at least one grade at one month in 25 (78 percent) of the 32 in whom angioplasty was successful, as compared with only 1(11 percent) of the 9 in whom the procedure was unsuccessful (P<0.001). Although the mean wall-motion score was essentially the same in both groups before angioplasty (3.1±0.2 for patients with successful angioplasty vs. 3.3±0.2 for those with unsuccessful angioplasty, P = 0.50), one month later it had improved significantly in those in whom angioplasty was successful (1.9±0.2) but not in those in whom it was unsuccessful (3.6±0.03, P<0.001).

Collateral Flow Measured by Myocardial Contrast Echocardiography

The percentage of the infarct bed supplied by collateral flow was similar in patients in whom angioplasty was successful and patients in whom it was unsuccessful (73±5 percent vs. 67±14 percent, P = 0.58). Since the mean score for regional function improved only in the group that underwent successful angioplasty, the relation between regional function and collateral flow was examined in the 32 patients in this group who had abnormal wall motion at base line. For these patients, there was a significant inverse correlation (r = -0.64, P<0.001) between the percentage of the infarct bed supplied by collateral flow at base line and the wall-motion score one month later (Fig. 2Figure 2Correlation between the Wall-Motion Score One Month after Successful Angioplasty and the Mean (±SEM) Percentage of the Infarct Bed Supplied by Collateral Blood Flow at Base Line.). This correlation was essentially unchanged (r = -0.66, P<0.001) when the 10 patients with multivessel disease, a previous infarction, or both were excluded from the analysis.

As Figure 3Figure 3Mean (±SEM) Wall-Motion Score in Patients with Good and Poor Collateral Blood Flow on Myocardial Contrast Echocardiography. shows (left panel), the wall-motion score within the infarct zone was not significantly different at base line in the 23 patients in whom >50 percent of the bed was supplied by collateral flow and in the 9 in whom ≤50 percent was supplied by collateral flow (P = 0.18). The wall-motion score was significantly lower than the base-line score one month after successful angioplasty in the group with more extensive collateral flow (3.0±0.2 vs. 1.6±0.2, P<0.001), whereas it did not change significantly in the group with less extensive collateral flow (3.4±0.2 vs. 2.9±0.3, P = 0.14). Consequently, as Figure 3 shows (right panel), the change in the wall-motion score within the infarct bed was significantly greater in those in whom >50 percent of the infarct bed was supplied by collateral flow than in those in whom ≤50 percent of the bed was supplied by such flow (1.4±0.2 vs. 0.6±0.2, P = 0.004).

The extent of the perfusion of myocardium by the infarct-related artery, expressed as a percentage of the left ventricular short-axis image, was similar in patients in whom ≤50 percent of the infarct bed was supplied by collateral flow and in those in whom >50 percent was so supplied (32±2 percent vs. 31±4 percent, P = 0.70). The size of the perfusion bed was not correlated with the percentage of the bed supplied by collateral flow (r = 0.18), with the wall-motion score (r = 0.07), or with the degree of improvement in the score one month after successful angioplasty (r = 0.23).

Collateral Flow Measured by Angiography

The presence of collateral vessels on angiography did not correlate with either base-line wall motion or the change in wall motion in the patients who had abnormal wall motion at base line. There was poor correlation between the collateral-vessel grade on angiography and the wall-motion score one month after successful angioplasty (r = -0.24, P = 0.16). The 15 patients with a low grade for collateral vessels (0 or 1) on angiography had the same mean base-line regional-wall-motion score as the 17 with good supply by collateral vessels (grade 2 or 3) (3.2±0.2 vs. 3.0±0.2, P = 0.37). The change in the wall-motion score after successful angioplasty was also similar for patients with angiographic evidence of poor or good supply by collateral vessels (1.1±0.3 vs. 1.2±0.1, P = 0.73). There was poor correlation between the percentage of the infarct bed supplied by collateral flow as determined by contrast echocardiography and the collateral-vessel grade on angiography (r = 0.05) in the 43 patients for whom data were analyzed. Seven of the nine patients in whom ≤50 percent of the infarct bed was supplied by collateral flow had good collateral blood supply (grade 2 or 3) on angiography.

Improvement in Wall Motion and the Duration of Coronary Occlusion

There was no relation between the probability and degree of improvement in wall motion and the interval between the myocardial infarction and the attempt at angioplasty (Table 2Table 2Improvement in Regional Function after Angioplasty, According to the Length of Time between Acute Myocardial Infarction (MI) and Angioplasty.*). Seven (64 percent) of the 11 patients who underwent the procedure between two and seven days after myocardial infarction, 10 (77 percent) of the 13 who underwent angioplasty one to two weeks after infarction, and all of the 8 patients who underwent angioplasty two to five weeks after infarction had improvement in wall-motion score (P = 0.17). Substantial improvement occurred in all three groups, without any significant differences in the degree of improvement among the groups (P = 0.99).

Discussion

This prospective study demonstrates that collateral-derived residual flow is present in many patients with a recent myocardial infarction and an occluded infarct-related artery. This blood flow maintains myocardial viability for a prolonged period despite total coronary occlusion, and restoration of anterograde blood flow as late as five weeks after myocardial infarction results in improvement in regional function even in patients with severe regional dysfunction, as long as they have adequate collateral flow at base line. Moreover, the degree of regional function after the restoration of anterograde flow is related to the percentage of the occluded bed perfused by collateral flow.

The Role of Collateral Blood Flow in Myocardial Infarction

That there is controversy about the importance of collateral blood flow in acute ischemic syndromes29 , 30 may be due in part to the methods used heretofore to assess collateral vessels in humans. Coronary angiography, the most frequently used diagnostic technique for the assessment of collateral vessels, has several limitations. It can identify only vessels >100 μm in diameter,13 although most arterial collateral vessels are smaller.14 Furthermore, although it can demonstrate the presence of epicardial collateral vessels, it does not specify the distribution of collateral flow within the myocardium.

Because of these limitations, the beneficial effects of angiographically identified collateral vessels on left ventricular function in patients who receive early reperfusion therapy during acute myocardial infarction have also become controversial. Saito et al.,9 Rentrop and coworkers,10 and Habib and colleagues11 reported beneficial effects of collateral vessels in such cases. Gohlke et al.,12 however, reported that the presence of collateral vessels did not protect against long-term adverse effects in patients with anterior Q-wave myocardial infarctions.

In this study, we have shown that the distribution of collateral blood flow within the occluded infarct bed is related to myocardial viability and that this distribution does not correlate with the collateral-vessel grade determined angiographically. Patients with poor collateral flow, as measured by myocardial contrast echocardiography, did not have improvement in regional function despite having good angiographic evidence of collateral vessels and despite undergoing successful angioplasty. The percentage of a perfusion bed supplied by collateral flow was also independent of the size of the perfusion bed itself. Thus, improvement in regional function after successful angioplasty was not limited to patients with infarct-related arteries that supply small perfusion beds.

It is generally believed that the improvement of regional function, the limitation of infarct expansion, and the prevention of heart failure and death are closely related to myocardial salvage, which can be achieved by reperfusion only in the first few hours after the onset of myocardial infarction.1 , 2 Our results indicate that substantial benefit may also be gained from reperfusion as late as five weeks after infarction in patients with persistent occlusion of the infarct-related artery, as long as collateral blood flow is present within the infarct bed.

The Value of Reperfusion Late after Myocardial Infarction

It is only recently that improved survival and better regional function have been reported in patients in whom patency of the infarct-related artery is restored late after myocardial infarction.31 32 33 34 35 36 A number of mechanisms have been suggested to explain the benefit of late reperfusion, including a decrease in fatal ventricular arrhythmias37 and the limitation of infarct expansion.38 , 39 A recent study by Topol and colleagues found that left ventricular dilatation was prevented at one month in patients who underwent late reperfusion.40 The lack of a persistent difference between treated and untreated patients after six months in that study may be due in part to the incomplete follow-up in a substantial proportion of patients, to coronary reocclusion in one fourth of the successfully treated patients, and to spontaneous recanalization in some untreated patients. Contrary to the mechanisms proposed above, our results suggest that late reperfusion may provide clinical benefit by improving the function of viable myocardium that is present within the infarct zone in most patients with acute myocardial infarction.

Limitations of the Study

Although there were no statistical differences in base-line characteristics between patients in whom angioplasty was successful and those in whom it was unsuccessful, our results are based on small numbers with wide confidence intervals; there is thus the potential for beta error. The extent to which the patients in our study represent an unselected population is also uncertain. The majority had single-vessel disease and thus did not have jeopardized collateral vessels. In addition, only one fifth of our patients had objective evidence of ischemia after infarction. We therefore believe that our results apply to a considerable number of patients with acute myocardial infarction.

In patients in whom angioplasty was successful, we did not repeat angiography one month later to determine whether the infarct-related artery was still patent. There were no clinical events to indicate reocclusion, however. We measured the size of the perfusion bed and the extent of collateral flow only in a single short-axis echocardiographic view, which may not have represented the topography of the entire infarct bed accurately. Some of the collateral vessels noted in our patients could have developed after the infarction, but their presence nonetheless indicates the presence of viable myocardium, since collateral growth usually occurs in response to tissue need.41 , 42 Therefore, we can report only an association, rather than a causal relation, between collateral blood flow and myocardial viability.

Clinical Implications

This study was not designed to assess the value of coronary angioplasty in patients with recent myocardial infarction and an occluded infarct-related artery. Instead, its purpose was to determine whether there was an association between improvement in regional function within an infarct bed after late reperfusion and the extent of collateral blood flow to that bed before reperfusion. Our data suggest that improvement in function after late reperfusion may explain the clinical benefit seen in other studies among patients in whom patency of the infarct-related artery was reestablished late after myocardial infarction.31 32 33 34 35 36 , 40 Our results do not, however, necessarily indicate that angioplasty should be performed in all patients with acute infarction who have an occluded infarct-related artery and adequate collateral blood flow. Randomized studies of the long-term effects of angioplasty in such patients will be required before this important question can be answered.

Supported in part by a Clinical Investigator Award to Dr. Kaul (K08-HL01833) and a FIRST Award (R29-HL38345) from the National Institutes of Health and by a grant-in-aid from the Virginia affiliate of the American Heart Association. Dr. Ragosta was the recipient of a fellowship training grant from the Virginia affiliate of the American Heart Association, and Dr. Kaul is an Established Investigator of the American Heart Association, Dallas.

Presented in part at the 64th Annual Scientific Session of the American Heart Association (Samuel Levine Young Investigators' Award Competition), Anaheim, Calif., November 11, 1991.

Source Information

From the Division of Cardiology, Department of Medicine, University of Virginia School of Medicine, Charlottesville. Address reprint requests to Dr. Powers at the Division of Cardiology, Box 158, University of Virginia, Charlottesville, VA 22908.

References

References

  1. 1

    Schaper W, Frenzel H, Hort W. Experimental coronary artery occlusion. I. Measurement of infarct size . Basic Res Cardiol 1979;74:46–53.
    CrossRef | Web of Science | Medline

  2. 2

    Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow . Lab Invest 1979;40:633–44.
    Web of Science | Medline

  3. 3

    Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction . Lancet 1986;1:397–402.
    Web of Science | Medline

  4. 4

    Kennedy JW, Ritchie JL, Davis KB, Stadius ML, Maynard C, Fritz JK. The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: a 12-month follow-up report . N Engl J Med 1985;312:1073–8.
    Full Text | Web of Science | Medline

  5. 5

    The I.S.A.M. Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days . N Engl J Med 1986;314:1465–71.
    Full Text | Web of Science | Medline

  6. 6

    Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET) . Lancet 1988;2:525–30.
    CrossRef | Web of Science | Medline

  7. 7

    AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial . Lancet 1988;1:545–9.
    Web of Science | Medline

  8. 8

    Simoons ML, Serruys PW, van den Brand M, et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival . J Am Coll Cardiol 1986;7:717–28.
    CrossRef | Web of Science | Medline

  9. 9

    Saito Y, Yasuno M, Ishida M, et al. Importance of coronary collaterals for restoration of left ventricular function after intracoronary thrombolysis . Am J Cardiol 1985;55:1259–63.
    CrossRef | Web of Science | Medline

  10. 10

    Rentrop KP, Feit F, Sherman W, et al. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai—New York University Reperfusion Trial . J Am Coll Cardiol 1989;14:58–64.
    CrossRef | Web of Science | Medline

  11. 11

    Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans: results of phase I thrombolysis in myocardial infarction (TIMI) trial . Circulation 1991;83:739–46.
    Web of Science | Medline

  12. 12

    Gohlke H, Heim E, Roskamm H. Prognostic importance of collateral flow and residual coronary stenosis of the myocardial infarct artery after anterior wall Q-wave acute myocardial infarction . Am J Cardiol 1991;67:1165–9.
    CrossRef | Web of Science | Medline

  13. 13

    Gensini GG, Bruto da Costa BC. The coronary collateral circulation in living man . Am J Cardiol 1969;24:393–400.
    CrossRef | Web of Science | Medline

  14. 14

    Morphologic considerations of the coronary collateral circulation in man. In: Cohen MV. Coronary collaterals: clinical and experimental observations. Mount Kisco, N.Y.: Futura, 1985:1–91.

  15. 15

    Kaul S, Gillam LD, Weyman AE. Contrast echocardiography in acute myocardial ischemia. II. The effect of site of injection of contrast agent on the estimation of area at risk for necrosis after coronary occlusion . J Am Coll Cardiol 1985;6:825–30.
    CrossRef | Web of Science | Medline

  16. 16

    Kaul S, Pandian NG, Guerrero JL, Gillam LD, Okada RD, Weyman AE. Effects of selectively altering the collateral driving pressure on regional perfusion and function in the occluded coronary bed in the dog . Circ Res 1987;61:77–85.
    Web of Science | Medline

  17. 17

    Spotnitz WD, Matthew TL, Keller MW, Powers ER, Kaul S. Intraoperative demonstration of coronary collateral flow using myocardial contrast two-dimensional echocardiography . Am J Cardiol 1990;65:1259–61.
    CrossRef | Web of Science | Medline

  18. 18

    Kaul S, Glasheen WP, Oliner JD, Kelly P, Gascho JA. Relation between anterograde blood flow through a coronary artery and the size of the perfusion bed it supplies: experimental and clinical implications . J Am Coll Cardiol 1991;17:1403–13.
    CrossRef | Web of Science | Medline

  19. 19

    Grill HP, Brinker JA, Taube JC, et al. Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty . J Am Coll Cardiol 1990;16:1594–600.
    CrossRef | Web of Science | Medline

  20. 20

    Lim YJ, Nanto S, Masuyama T, et al. Coronary collaterals assessed with myocardial contrast echocardiography in healed myocardial infarction . Am J Cardiol 1990;66:556–61.
    CrossRef | Web of Science | Medline

  21. 21

    Sabia PJ, Powers ER, Jayaweera AR, Ragosta M, Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction: a study using myocardial contrast echocardiography . Circulation 1992;85:2080–9.
    Web of Science | Medline

  22. 22

    Keller MW, Glasheen WP, Teja K, Gear A, Kaul S. Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of regional myocardial perfusion . J Am Coll Cardiol 1988;12:1039–47.
    CrossRef | Web of Science | Medline

  23. 23

    Moore CA, Smucker ML, Kaul S. Myocardial contrast echocardiography in humans. I. Safety — a comparison with routine coronary arteriography . J Am Coll Cardiol 1986;8:1066–72.
    CrossRef | Web of Science | Medline

  24. 24

    Lang RM, Feinstein SB, Feldman T, Neumann A, Chua KG, Borow KM. Contrast echocardiography for evaluation of myocardial perfusion: effects of coronary angioplasty . J Am Coll Cardiol 1986;8:232–5.
    CrossRef | Web of Science | Medline

  25. 25

    Kaul S, Kelly P, Oliner JD, Glasheen WP, Keller MW, Watson DD. Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography . J Am Coll Cardiol 1989;13:468–82.
    CrossRef | Web of Science | Medline

  26. 26

    Kaul S, Pandian NG, Gillam LD, Newell JB, Okada RD, Weyman AE. Contrast echocardiography in acute myocardial ischemia. III. An in vivo comparison of the extent of abnormal wall motion with the area at risk for necrosis . J Am Coll Cardiol 1986;7:383–92.
    CrossRef | Web of Science | Medline

  27. 27

    Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography . J Am Coll Cardiol 1989;13:1506–13.
    CrossRef | Web of Science | Medline

  28. 28

    Mood AM, Graybill FA. Introduction to the theory of statistics. 2nd ed. New York: McGraw-Hill, 1963.

  29. 29

    Gorlin R. Coronary collaterals . Major Probl Intern Med 1976;11:59–70.
    Medline

  30. 30

    Functional significance of coronary collaterals in man. In: Cohen MV. Coronary collaterals: clinical and experimental observations. Mount Kisco, N.Y.: Futura, 1985:93–185.

  31. 31

    ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2 . Lancet 1988;2:349–60.
    Web of Science | Medline

  32. 32

    Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials . Eur Heart J 1985;6:556–85.
    Web of Science | Medline

  33. 33

    Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens CH. Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials . N Engl J Med 1982;307:1180–2.
    Full Text | Web of Science | Medline

  34. 34

    Dalen JE, Gore JM, Braunwald E, et al. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial . Am J Cardiol 1988;62:179–85.
    CrossRef | Web of Science | Medline

  35. Erratum, Am J Cardiol 1988;62:1151.
    Web of Science | Medline

  36. 35

    Schroder R, Neuhaus KL, Linderer T, Bruggemann T, Tebbe U, Wegscheider K. Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM study) . Am J Cardiol 1989;64:878–84.
    CrossRef | Web of Science | Medline

  37. 36

    Finci L, Meier B, Favre J, Righetti A, Rutishauser W. Long-term results of successful and failed angioplasty for chronic total coronary artery occlusion . Am J Cardiol 1990;66:660–2.
    CrossRef | Web of Science | Medline

  38. 37

    Kersschot IE, Brugada P, Ramentol M, et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study . J Am Coll Cardiol 1986;7:1234–42.
    CrossRef | Web of Science | Medline

  39. 38

    Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage . Circulation 1987;75:299–306.
    CrossRef | Web of Science | Medline

  40. 39

    Force T, Kemper A, Leavitt M, Parisi AF. Acute reduction in functional infarct expansion with late coronary reperfusion: assessment with quantitative two-dimensional echocardiography . J Am Coll Cardiol 1988;11:192–200.
    CrossRef | Web of Science | Medline

  41. 40

    Topol EJ, Califf RM, Vandormael M, et al. A randomized trial of late reperfusion therapy for acute myocardial infarction . Circulation 1992;85: 2090–9.
    Web of Science | Medline

  42. 41

    Mulvihill DA, Harvey SC. The mechanism of the development of collateral circulation . N Engl J Med 1931;204:1032–4.
    Full Text | Web of Science

  43. 42

    Schaper W. Collateral pressure-flow relationships in acute and chronic artery occlusion. In: Schaper W, ed. Collateral circulation of the heart. New York: Elsevier Science, 1971:155–79.

Citing Articles (136)

Citing Articles

  1. 1

    Michael P Robich, Louis M Chu, Shizu Oyamada, Neel R Sodha, Frank W Sellke. (2011) Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles. Expert Review of Cardiovascular Therapy 9:11, 1469-1479
    CrossRef

  2. 2

    Paul F.A. Teunissen, Anton J.G. Horrevoets, Niels van Royen. (2011) The coronary collateral circulation: Genetic and environmental determinants in experimental models and humans. Journal of Molecular and Cellular Cardiology
    CrossRef

  3. 3

    Mohammad Alidoosti, Mahboobeh Ghaedi, Abbas Soleimani, Salar Bakhtiyari, Mehrnaz Rezvanfard, Shekufeh Golkhu, Narges Mohammadtaghvaei. (2011) Study on the role of environmental parameters and HIF-1A gene polymorphism in coronary collateral formation among patients with ischemic heart disease. Clinical Biochemistry
    CrossRef

  4. 4

    Semenza, Gregg L., . (2011) Oxygen Sensing, Homeostasis, and Disease. New England Journal of Medicine 365:6, 537-547
    Full Text

  5. 5

    Wen-Wei Yue, Feng-Tian Huangfu, Jie Yin, Tao Wang, Guang-Fu Wang, Ru-Yi Jia. (2011) Assessment of Recanalization of Chronic Total Occlusions on Left Ventricular Function in Patients With or Without Previous Myocardial Infarction by Real-time Three-Dimensional Echocardiography. Cell Biochemistry and Biophysics
    CrossRef

  6. 6

    Michael Ragosta. (2011) Techniques for Phenotyping Coronary Artery Disease in the Cardiac Catheterization Laboratory for Applications in Translational Research. Journal of Cardiovascular Translational Research 4:4, 385-392
    CrossRef

  7. 7

    Jing Gao, Mei Shen, Xuejiang Guo, Xiaojie Li, Jianan Li. (2011) Proteomic Mechanism of Myocardial Angiogenesis Augmented by Remote Ischemic Training of Skeletal Muscle in Rabbit. Cardiovascular Therapeutics 29:3, 199-210
    CrossRef

  8. 8

    Philipp Bahrmann, Justus Rach, Steffen Desch, Gerhard C. Schuler, Holger Thiele. (2011) Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy. Clinical Research in Cardiology 100:5, 457-467
    CrossRef

  9. 9

    Scott M. Chadderdon, Sanjiv Kaul. (2011) Myocardial contrast echocardiography in coronary artery disease. Journal of Cardiovascular Echography 21:1, 1-11
    CrossRef

  10. 10

    James E. Udelson, Camille A. Pearte, Carey D. Kimmelstiel, Mariusz Kruk, Joseph A. Kufera, Sandra A. Forman, Anna Teresinska, Bartosz Bychowiec, Jose Antonio Marin-Neto, Thomas Höchtl, Eric A. Cohen, Paulo Caramori, Benita Busz-Papiez, Christopher Adlbrecht, Zygmunt P. Sadowski, Witold Ruzyllo, Debra J. Kinan, Gervasio A. Lamas, Judith S. Hochman. (2011) The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone. American Heart Journal 161:3, 611-621
    CrossRef

  11. 11

    Brian B. Løgstrup, Dan E. Høfsten, Thomas B. Christophersen, Jacob E. Møller, Hans E. Bøtker, Patricia A. Pellikka, Kenneth Egstrup. (2011) Persistent Abnormal Coronary Flow Reserve in Association with Abnormal Glucose Metabolism Affects Prognosis in Acute Myocardial Infarction. Echocardiography 28:2, 210-218
    CrossRef

  12. 12

    Asife Sahinarslan, Sinan A. Kocaman, Salih Topal, Ugur Ercin, Neslihan Bukan, Ridvan Yalcin, Timur Timurkaynak. (2010) Relation between serum monocyte chemoattractant protein-1 and coronary collateral development. Coronary Artery Disease 21:8, 455-459
    CrossRef

  13. 13

    Alessandro Fontanelli, Carlo Bonanno. (2010) Primary percutaneous coronary intervention in ‘early’ latecomers with ST-segment elevation acute myocardial infarction: the role of the infarct-related artery status. Journal of Cardiovascular Medicine1
    CrossRef

  14. 14

    Daniel P Sieveking, Renée WY Chow, Martin KC Ng. (2010) Androgens, angiogenesis and cardiovascular regeneration. Current Opinion in Endocrinology, Diabetes and Obesity 17:3, 277-283
    CrossRef

  15. 15

    S. Rey, G. L. Semenza. (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovascular Research 86:2, 236-242
    CrossRef

  16. 16

    Tadamichi Sakuma, Chikaaki Motoda, Takehito Tokuyama, Toshiharu Oka, Hiromichi Tamekiyo, Takenori Okada, Masaya Otsuka, Tomokazu Okimoto, Mamoru Toyofuku, Hidekazu Hirao, Yuji Muraoka, Hironori Ueda, Yoshiko Masaoka, Yasuhiko Hayashi. (2010) Exogenous adenosine triphosphate disodium administration during primary percutaneous coronary intervention reduces no-reflow and preserves left ventricular function in patients with acute anterior myocardial infarction: A study using myocardial contrast echocardiography. International Journal of Cardiology 140:2, 200-209
    CrossRef

  17. 17

    Edouard Gerbaud, Alexandre Faury, Pierre Coste, Matthew Erickson, Olivier Corneloup, Pierre Dos Santos, Catherine Durrieu-Jaïs, François Laurent, Michel Montaudon. (2010) Comparative Analysis of Cardiac Magnetic Resonance Viability Indexes to Predict Functional Recovery After Successful Percutaneous Coronary Intervention in Acute Myocardial Infarction. The American Journal of Cardiology 105:5, 598-604
    CrossRef

  18. 18

    Wei Huang, Jack Rubinstein, Alejandro R Prieto, Donna H Wang. (2010) Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-β-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels. Journal of Hypertension 28:2, 367-376
    CrossRef

  19. 19

    John C. Chatham, Richard B. Marchase. (2010) The role of protein O-linked β-N-acetylglucosamine in mediating cardiac stress responses. Biochimica et Biophysica Acta (BBA) - General Subjects 1800:2, 57-66
    CrossRef

  20. 20

    Sanjiv Kaul. (2010) Myocardial Contrast Echocardiography. JACC: Cardiovascular Imaging 3:2, 212-218
    CrossRef

  21. 21

    Girish Dwivedi, Rajesh Janardhanan, Sajad A. Hayat, Tiong K. Lim, Roxy Senior. (2009) Comparison Between Myocardial Contrast Echocardiography and 99mTechnetium Sestamibi Single Photon Emission Computed Tomography Determined Myocardial Viability in Predicting Hard Cardiac Events Following Acute Myocardial Infarction. The American Journal of Cardiology 104:9, 1184-1188
    CrossRef

  22. 22

    Se-Jung Yoon, Young-Guk Ko, Jung-Sun Kim, Jae-Youn Moon, Young-Jin Kim, Sungha Park, Jong-Won Ha, Donghoon Choi, Yangsoo Jang, Namsik Chung, Won-Heum Shim, Seung-Yun Cho. (2009) Impact of coronary artery collaterals on infarct size assessed by serial cardiac magnetic resonance imaging after primary percutaneous coronary intervention in patients with acute myocardial infarction. Coronary Artery Disease 20:7, 440-445
    CrossRef

  23. 23

    Ramazan Topsakal, Mehmet G. Kaya, Mustafa Duran, Ozgur Gunebakmaz, Ali Dogan, Tugrul Inanc, Mikail Yarlioglues, Ahmet Celik, Ali Ergin. (2009) The relation between microalbuminuria and coronary collateral vessel development in patients with unstable coronary artery disease. Coronary Artery Disease 20:7, 431-434
    CrossRef

  24. 24

    Irene Lang, Sandra Forman, Aldo Maggioni, Witold Ruzyllo, Jean Renkin, Carlos Vozzi, P. Gabriel Steg, Jose-Maria Hernandez-Garcia, Krzysztof Zmudka, Manuel Jimenez-Navarro, George Sopko, Gervasio Lamas, Judith Hochman. (2009) Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT). EuroIntervention 5:5, 610-618
    CrossRef

  25. 25

    E. E. Buschmann, W. Utz, N. Pagonas, J. Schulz-Menger, A. Busjahn, J. Monti, W. Maerz, F. le Noble, L. Thierfelder, R. Dietz, V. Klauss, M. Gross, I.R. Buschmann, . (2009) Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial). European Journal of Clinical Investigation 39:10, 866-875
    CrossRef

  26. 26

    M. Busk, A. Kaltoft, S. S. Nielsen, M. Bottcher, M. Rehling, L. Thuesen, H. E. Botker, J. F. Lassen, E. H. Christiansen, L. R. Krusell, H. R. Andersen, T. T. Nielsen, S. D. Kristensen. (2009) Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. European Heart Journal 30:11, 1322-1330
    CrossRef

  27. 27

    Stephen P. Hoole, Paul A. White, Patrick M. Heck, Sadia N. Khan, Cameron G. Densem, Sarah C. Clarke, Leonard M. Shapiro, Peter M. Schofield, Michael OʼSullivan, David P. Dutka. (2009) Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis. Coronary Artery Disease 20:4, 253-259
    CrossRef

  28. 28

    Peipei Wang, Joshua M. Tate, Steven G. Lloyd. (2008) Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia. Life Sciences 83:25-26, 836-844
    CrossRef

  29. 29

    Ugo Testa, Gaetano Pannitteri, Gian Luigi Condorelli. (2008) Vascular endothelial growth factors in cardiovascular medicine. Journal of Cardiovascular Medicine 9:12, 1190-1221
    CrossRef

  30. 30

    Hun-Jun Park, Kiyuk Chang, Chan Seok Park, Sung Won Jang, Sang-Hyun Ihm, Pum Joon Kim, Sang-Hong Baek, Ki-Bae Seung, Kyu-Bo Choi. (2008) Coronary collaterals: The role of MCP-1 during the early phase of acute myocardial infarction. International Journal of Cardiology 130:3, 409-413
    CrossRef

  31. 31

    V. Menon, C. A. Pearte, C. E. Buller, Ph.G. Steg, S. A. Forman, H. D. White, P. N. Marino, D. G. Katritsis, P. Caramori, R. Lasevitch, K. Loboz-Grudzien, A. Zurakowski, G. A. Lamas, J. S. Hochman. (2008) Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. European Heart Journal 30:2, 183-191
    CrossRef

  32. 32

    Antonio Abbate, Giuseppe G.L. Biondi-Zoccai, Darryn L. Appleton, Paul Erne, Andreas W. Schoenenberger, Michael J. Lipinski, Pierfrancesco Agostoni, Imad Sheiban, George W. Vetrovec. (2008) Survival and Cardiac Remodeling Benefits in Patients Undergoing Late Percutaneous Coronary Intervention of the Infarct-Related Artery. Journal of the American College of Cardiology 51:9, 956-964
    CrossRef

  33. 33

    Sammy Elmariah, Sidney C Smith, Valentin Fuster. (2008) Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction. Nature Clinical Practice Cardiovascular Medicine 5:1, 42-52
    CrossRef

  34. 34

    Jessica de Vries, Rutger L. Anthonio, Ad F.M. van den Heuvel, Eng-Shiong Tan, Gillian A. Jessurun, Bart J.G.L. de Smet, Mike J.L. DeJongste, Felix Zijlstra. (2007) Incidence and angiographic predictors of collateral function in patients with stable coronary artery disease scheduled for percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 70:2, 197-202
    CrossRef

  35. 35

    Paul Sorajja, Bernard J. Gersh, Roxana Mehran, Alexandra J. Lansky, Mitchell W. Krucoff, John Webb, David A. Cox, Bruce R. Brodie, Gregg W. Stone. (2007) Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction. American Heart Journal 154:2, 379-384
    CrossRef

  36. 36

    Girish Dwivedi, Rajesh Janardhanan, Sajad A. Hayat, John M. Swinburn, Roxy Senior. (2007) Prognostic Value of Myocardial Viability Detected by Myocardial Contrast Echocardiography Early After Acute Myocardial Infarction. Journal of the American College of Cardiology 50:4, 327-334
    CrossRef

  37. 37

    Lin Piao, Jingdong Li, Meredith McLerie, Anatoli N. Lopatin. (2007) Cardiac IK1 underlies early action potential shortening during hypoxia in the mouse heart. Journal of Molecular and Cellular Cardiology 43:1, 27-38
    CrossRef

  38. 38

    Jeroen Koerselman, Peter P.Th. de Jaegere, Marianne C. Verhaar, Diederick E. Grobbee, Yolanda van der Graaf. (2007) Coronary collateral circulation: The effects of smoking and alcohol. Atherosclerosis 191:1, 191-198
    CrossRef

  39. 39

    KangAe Lee, Robert A. Roth, John J. LaPres. (2007) Hypoxia, drug therapy and toxicity. Pharmacology & Therapeutics 113:2, 229-246
    CrossRef

  40. 40

    Yoshiyuki Takami, Hiroshi Masumoto. (2007) Angiographic Fate of Collateral Vessels After Surgical Revascularization of the Totally Occluded Left Anterior Descending Artery. The Annals of Thoracic Surgery 83:1, 120-125
    CrossRef

  41. 41

    Hochman, Judith S., Lamas, Gervasio A., Buller, Christopher E., Dzavik, Vladimir, Reynolds, Harmony R., Abramsky, Staci J., Forman, Sandra, Ruzyllo, Witold, Maggioni, Aldo P., White, Harvey, Sadowski, Zygmunt, Carvalho, Antonio C., Rankin, Jamie M., Renkin, Jean P., Steg, P. Gabriel, Mascette, Alice M., Sopko, George, Pfisterer, Matthias E., Leor, Jonathan, Fridrich, Viliam, Mark, Daniel B., Knatterud, Genell L., . (2006) Coronary Intervention for Persistent Occlusion after Myocardial Infarction. New England Journal of Medicine 355:23, 2395-2407
    Full Text

  42. 42

    S. Kaul. (2006) Evaluating the ‘no reflow’ phenomenon with myocardial contrast echocardiography. Basic Research in Cardiology 101:5, 391-399
    CrossRef

  43. 43

    Katina M. Corley, Caroline J. Taylor, Brenda Lilly. (2005) Hypoxia-inducible factor 1α modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells. Journal of Cellular Biochemistry 96:5, 971-985
    CrossRef

  44. 44

    J Koerselman, P P Th de Jaegere, M C Verhaar, Y van der Graaf, D E Grobbee. (2005) High blood pressure is inversely related with the presence and extent of coronary collaterals. Journal of Human Hypertension 19:10, 809-817
    CrossRef

  45. 45

    Ferdinando Carlo Sasso, Daniele Torella, Ornella Carbonara, Georgina M. Ellison, Michele Torella, Michelangelo Scardone, Claudio Marra, Rodolfo Nasti, Raffaele Marfella, Domenico Cozzolino, Ciro Indolfi, Maurizio Cotrufo, Roberto Torella, Teresa Salvatore. (2005) Increased Vascular Endothelial Growth Factor Expression But Impaired Vascular Endothelial Growth Factor Receptor Signaling in the Myocardium of Type 2 Diabetic Patients With Chronic Coronary Heart Disease. Journal of the American College of Cardiology 46:5, 827-834
    CrossRef

  46. 46

    Jeroen Koerselman, Peter P. Th. Jaegere, Marianne C. Verhaar, Diederick E. Grobbee, Yolanda van Graaf, . (2005) Cardiac Ischemic Score Determines the Presence of Coronary Collateral Circulation. Cardiovascular Drugs and Therapy 19:4, 283-289
    CrossRef

  47. 47

    Roby D. Rakhit, Christian Seiler, Kerstin Wustmann, Stephan Zbinden, Stephan Windecker, Bernhard Meier, Franz R Eberli. (2005) Tumour necrosis factor-alpha and interleukin-6 release during primary percutaneous coronary intervention for acute myocardial infarction is related to coronary collateral flow. Coronary Artery Disease 16:3, 147-152
    CrossRef

  48. 48

    Howard Leong-Poi, Matthew P. Coggins, Jiri Sklenar, Ananda R. Jayaweera, Xin-Qun Wang, Sanjiv Kaul. (2005) Role of collateral blood flow in the apparent disparity between the extent of abnormal wall thickening and perfusion defect size during acute myocardial infarction and demand ischemia. Journal of the American College of Cardiology 45:4, 565-572
    CrossRef

  49. 49

    Vipul R. Panchal, Jalees Rehman, Anne T. Nguyen, John W. Brown, Mark W. Turrentine, Yousuf Mahomed, Keith L. March. (2004) Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease. Journal of the American College of Cardiology 43:8, 1383-1387
    CrossRef

  50. 50

    Shota Fukuda, Takeshi Hozumi, Takashi Muro, Hiroyuki Watanabe, Eiichi Hyodo, Minoru Yoshiyama, Kazuhide Takeuchi, Junichi Yoshikawa. (2004) Quantitative Intravenous Myocardial Contrast Echocardiography Predicts Recovery of Left Ventricular Function After Revascularization in Chronic Coronary Artery Disease. Echocardiography 21:2, 119-124
    CrossRef

  51. 51

    Akiko Iwata, Fuminobu Ishikura, Kentaro Ohtani, Tsutomu Toshida, Toshihiko Asanuma, Shintaro Beppu. (2004) Nicorandil Preserves Coronary Collateral Circulation Compared to Nitroglycerin Even in Systemic Hypotension: A Real-Time Myocardial Contrast Echocardiographic Study. Journal of Echocardiography 2:4, 90-98
    CrossRef

  52. 52

    Yasushi Akutsu, Yusuke Kodama, Hideki Nishimura, Yukihiko Kinohira, Hui-Ling Li, Hideyuki Yamanaka, Hiroyuki Kayano, Yuji Hamazaki, Akira Shinozuka, Takashi Katagiri. (2004) Contractile Reserve, Thallium-201 Reverse Redistribution and Mismatch Between Perfusion and Metabolism in Reperfused Infarct-related Myocardium With Delayed and Incomplete Functional Recovery. Japanese Heart Journal 45:5, 739-748
    CrossRef

  53. 53

    Ursula Klaar, Rudolf Berger, Marianne Gwechenberger, Michael Wutte, Gerold Porenta, Heinz Sochor, Gerald Maurer, Helmut Baumgartner. (2003) Relationship between dobutamine response of dyssynergic myocardium and angiographically documented blood supply. Journal of the American Society of Echocardiography 16:9, 949-957
    CrossRef

  54. 54

    A. Hagendorff, A. Goeckritz, A. Neugebauer, T. Rother, D. Pfeiffer, H. Becher. (2003) Intravenous Myocardial Contrast Echocardiography During Angioplasty. Echocardiography 20:6, 527-531
    CrossRef

  55. 55

    Gregg L. Semenza. (2003) Angiogenesis Ischemic and Neoplastic Disorders. Annual Review of Medicine 54:1, 17-28
    CrossRef

  56. 56

    Murat Sezer, Yilmaz Nisanci, Berrin Umman, Ercument Ylmaz, Fehmi Mercanoglu, Sabahattin Umman, Huseyin Oflaz, Onal Ozsaruhan. (2002) Can thrombolytic therapy provide beneficial effects additional to epicardial coronary artery recanalization? A study based on coronary pressure measurement*. Coronary Artery Disease 13:2, 125-130
    CrossRef

  57. 57

    Tadamichi Sakuma, Takenori Okada, Yasuhiko Hayashi, Masaya Otsuka, Yuukou Hirai. (2002) Optimal Time for Predicting Left Ventricular Remodeling After Successful Primary Coronary Angioplasty in Acute Myocardial Infarction Using Serial Myocardial Contrast Echocardiography and Magnetic Resonance Imaging. Circulation Journal 66:7, 685-685
    CrossRef

  58. 58

    Shoichi Miyamoto, Masatoshi Fujita, Kinzo Ueda, Shun-ichi Tamaki, Koji Hasegawa, Noritoshi Nagaya, Shigetake Sasayama. (2002) Shunt Between the Ventricular Chamber and Coronary Arteries Preserves Left Ventricular Function in Acute Myocardial Infarction. Circulation Journal 66:7, 633-633
    CrossRef

  59. 59

    Robert A. Pelberg, William D. Spotnitz, Jian-Ping Bin, Elizabeth Le, N. Craig Goodman, Sanjiv Kaul. (2001) Mechanism of myocardial dysfunction in the Presence of chronic coronary stenosis and Normal resting myocardial blood flow: Clinical implications. Journal of the American Society of Echocardiography 14:11, 1047-1056
    CrossRef

  60. 60

    Howard A. Cooper, Eugene Braunwald. (2001) Clinical importance of stunned and hibernating myocardium. Coronary Artery Disease 12:5, 387-392
    CrossRef

  61. 61

    Patricia Ugolini, Annie Delouche, Alain Herment, Benoit Diebold. (2001) In vitro quantification of flow using continuous infusion of Levovist and pairs of harmonic power Doppler images. Ultrasound in Medicine & Biology 27:5, 637-642
    CrossRef

  62. 62

    Gregg L. Semenza. (2000) Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. Journal of Clinical Investigation 106:7, 809-812
    CrossRef

  63. 63

    Lloyd Paul Aiello, Jun-Shyan Wong. (2000) Role of vascular endothelial growth factor in diabetic vascular complications. Kidney International 58:Suppl. 77, 113-119
    CrossRef

  64. 64

    James D Mills, David Fischer, Flordeliza S Villanueva. (2000) Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography. Journal of the American College of Cardiology 36:2, 618-624
    CrossRef

  65. 65

    Daniele Rovai, Maria-Aurora Morales, Robert Amyot, Antonio ' Abbate. (2000) Clinical Experience with SonoVue in Myocardial Perfusion Imaging. Echocardiography 17:s6, s17-s23
    CrossRef

  66. 66

    Farooq A. Chaudhry, Binoy Singh, and Kathleen Galatro. (2000) Reversible Left Ventricular Dysfunction. Echocardiography 17:5, 495-506
    CrossRef

  67. 67

    S Kaul. (2000) Current status of contrast echocardiography. ACC Current Journal Review 9:3, 73-75
    CrossRef

  68. 68

    Thomas H. Marwick. (2000) Overview. Coronary Artery Disease 11:3, 201-202
    CrossRef

  69. 69

    Flordeliza S. Villanueva. (2000) The use of myocardial contrast echocardiography in clinical evaluation after myocardial infarction. Coronary Artery Disease 11:3, 235-242
    CrossRef

  70. 70

    Ernst R Schwarz, Mark T Speakman, Mike Patterson, Sharon S Hale, Jeffrey M Isner, Laurence H Kedes, Robert A Kloner. (2000) Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formation. Journal of the American College of Cardiology 35:5, 1323-1330
    CrossRef

  71. 71

    Lee, Sang H., Wolf, Paul L., Escudero, Ryan, Deutsch, Reena, Jamieson, Stuart W., Thistlethwaite, Patricia A., . (2000) Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and Infarction. New England Journal of Medicine 342:9, 626-633
    Full Text

  72. 72

    KATHLEEN GALATRO, FAROOQ A. CHAUDHRY. (2000) Prognostic Implications of Myocardial Contractile Reserve in Patients with Ischemic Cardiomyopathy. Echocardiography 17:1, 61-67
    CrossRef

  73. 73

    Young-Jae Lim, Tohru Masuyama, Masayoshi Mishima, On Fukui, Daisaku Nakatani, Shigeo Kawano, Yasuhiko Sakata, Kazuhisa Kodama, Masatsugu Hori. (2000) Effect of pre-reperfusion residual flow on recovery from myocardial stunning: A myocardial contrast echocardiography study. Journal of the American Society of Echocardiography 13:1, 18-25
    CrossRef

  74. 74

    Thomas H. Marwick. (1999) Use of standard imaging techniques for prediction of postrevascularization functional recovery in patients with heart failure. Journal of Cardiac Failure 5:4, 334-346
    CrossRef

  75. 75

    Masatoshi Fujita, Ken-Ichi Otsuka, Izuru Nakae, Kinzo Ueda, Shun-Ichi Tamaki, Yasuki Kihara, Koji Hasegawa, Ryuji Nohara, Shigetake Sasayama. (1999) Determinants of collateral development in patients with acute myocardial infarction. Clinical Cardiology 22:9, 595-599
    CrossRef

  76. 76

    Takanori Yasu, Geert W Schmid-Schönbein, Bruno Cotter, Anthony N DeMaria. (1999) Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation. Journal of the American College of Cardiology 34:2, 578-586
    CrossRef

  77. 77

    Masami Nishino, Jun Tanouchi, Masayoshi Kawabata, Kenjiro Tanaka, Tatsuo Ito, Junji Kato, Yoshio Yamada, Takenobu Kamada. (1999) Evaluation of contrast agents for delineation of vessel wall boundary by intracoronary ultrasound after coronary angioplasty in human. Catheterization and Cardiovascular Interventions 47:1, 6-13
    CrossRef

  78. 78

    Rob A.M van Liebergen, Jan J Piek, Karel T Koch, Robbert J de Winter, Carl E Schotborgh, Kong I Lie. (1999) Quantification of collateral flow in humans: a comparison of angiographic, electrocardiographic and hemodynamic variables. Journal of the American College of Cardiology 33:3, 670-677
    CrossRef

  79. 79

    Arthur E. Stillman, Norbert Wilke, Michael Jerosch-Herold. (1999) MYOCARDIAL VIABILITY. Radiologic Clinics of North America 37:2, 361-378
    CrossRef

  80. 80

    Francesco Barillà, Giuseppe De Vincentis, Enrico Mangieri, Massimo Ciavolella, Gaetano Pannitteri, Francesco Scopinaro, Giuseppe Critelli, Pietro Paolo Campa. (1999) Recovery of contractility of viable myocardium during inotropic stimulation is not dependent on an increase of myocardial blood flow in the absence of collateral filling. Journal of the American College of Cardiology 33:3, 697-704
    CrossRef

  81. 81

    B.Zane Atkins, Cleveland W Lewis, William E Kraus, Kelley A Hutcheson, Donald D Glower, Doris A Taylor. (1999) Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ. The Annals of Thoracic Surgery 67:1, 124-129
    CrossRef

  82. 82

    Christian Firschke. (1998) Myokardiale Vitalitätsdiagnostik mittels Kontrastechokardiographie — Reif für die klinische Routineanwendung?. Herz 23:8, 483-490
    CrossRef

  83. 83

    Solomon Aronson, Eric Jacobsohn, Robert Savage, Mario Albertucci. (1998) The Influence of Collateral Flow on the Antegrade and Retrograde Distribution of Cardioplegia in Patients with an Occluded Right Coronary Artery. Anesthesiology 89:5, 1099-1107
    CrossRef

  84. 84

    DANIELE ROVAI, BIRGITTA JANEROT-SJÖBERG, ANDRÁS NAGY, CECILIA MARINI, SILVIA BURCHIELLI, MICHELE CASTELLARI, MARIA-AURORA MORALES, M. GIOVANNA TRIVELLA, JONNY OSTENSEN, ALESSANDRO DISTANTE, ANTONIO L'ABBATE. (1998) Myocardial Perfusion Abnormalities by Intravenous Administration of the Contrast Agent NC100100 in an Experimental Model of Coronary Artery Thrombosis and Reperfusion. Echocardiography 15:8, 731-740
    CrossRef

  85. 85

    Bruce R Brodie, Thomas D Stuckey, Thomas C Wall, Grace Kissling, Charles J Hansen, Denise B Muncy, Richard A Weintraub, Thomas A Kelly. (1998) Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Journal of the American College of Cardiology 32:5, 1312-1319
    CrossRef

  86. 86

    Andre Z Linka, Danny M Skyba, Richard J Price, Kevin Wei, Thomas C Skalak, Sanjiv Kaul. (1998) Spontaneous redistribution after reperfusion. Journal of the American College of Cardiology 32:6, 1765-1772
    CrossRef

  87. 87

    Matthias E Pfusterer, Peter Buser, Stefan Osswald, Philipp Weiss, Jens Bremerich, Felix Burkart. (1998) Time dependence of left ventricular recovery after delayed recanalization of an occluded infarct-related coronary artery: findings of a pilot study. Journal of the American College of Cardiology 32:1, 97-102
    CrossRef

  88. 88

    Athanassios Antonopoulos, Evangelos Georgiou, Michael Kyriakidis, Dimitrios Nikolopoulos, Pavlos Toutouzas, Charalambos Proukakis. (1998) Early postexercise thallium-201 reinjection after sublingual nitroglycerin augmentation: Effects on detection of myocardial ischemia and/or viability. Clinical Cardiology 21:6, 419-426
    CrossRef

  89. 89

    Michael L. Main, Jose F. Escobar, Shelley A. Hall, Anne L. Killam, Paul A. Grayburn. (1998) Detection of Myocardial Perfusion Defects by Contrast Echocardiography in the Setting of Acute Myocardial Ischemia with Residual Antegrade Flow. Journal of the American Society of Echocardiography 11:3, 228-235
    CrossRef

  90. 90

    A. Solomon, MD, B. Gersh, MD. (1998) THE OPEN-ARTERY HYPOTHESIS. Annual Review of Medicine 49:1, 63-76
    CrossRef

  91. 91

    Norman M. Kaplan, Biff F. Palmer, Paul A. Grayburn. (1998) Assessment of Myocardial "Reperfusion" by Contrast Echocardiography. The American Journal of the Medical Sciences 315:2, 124-132
    CrossRef

  92. 92

    Maurizio Salati, Massimo Lemma, Daniel G Di Mattia, Paolo Danna, Alessandro Cialfi, Antonino Salvaggio, Carmine Santoli. (1997) Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: Functional Observations. The Annals of Thoracic Surgery 64:6, 1728-1734
    CrossRef

  93. 93

    Yasuhiko Sakata, Kazuhisa Kodama, Masafumi Kitakaze, Tohru Masuyama, Atsushi Hirayama, Young-Jae Lim, Fuminobu Ishikura, Akihiko Sakai, Takayoshi Adachi, Masatsugu Hori. (1997) Different Mechanisms of Ischemic Adaptation to Repeated Coronary Occlusion in Patients With and Without Recruitable Collateral Circulation. Journal of the American College of Cardiology 30:7, 1679-1686
    CrossRef

  94. 94

    Thomas R Porter, Shouping Li, Karen Kilzer, Ubeydullah Deligonul. (1997) Effect of Significant Two-Vessel Versus One-Vessel Coronary Artery Stenosis on Myocardial Contrast Defects Observed With Intermittent Harmonic Imaging After Intravenous Contrast Injection During Dobutamine Stress Echocardiography. Journal of the American College of Cardiology 30:5, 1399-1406
    CrossRef

  95. 95

    Julio E. Pérez. (1997) Current role of contrast echocardiography in the diagnosis of cardiovascular diseases. Clinical Cardiology 20:S1, 31-38
    CrossRef

  96. 96

    C. Richard Conti. (1997) Hemodynamics, coronary angiography, and ventriculography can obviate the need for noninvasive studies in many patients with ischemic heart disease. Clinical Cardiology 20:10, 827-828
    CrossRef

  97. 97

    John C. Lualdi, Pamela S. Douglas. (1997) Echocardiography for the assessment of myocardial viability. Journal of the American Society of Echocardiography 10:7, 772-780
    CrossRef

  98. 98

    Sherif F Nagueh, Periyanan Vaduganathan, Nadir Ali, Alvin Blaustein, Mario S Verani, William L Winters, William A Zoghbi. (1997) Identification of Hibernating Myocardium: Comparative Accuracy of Myocardial Contrast Echocardiography, Rest-Redistribution Thallium-201 Tomography and Dobutamine Echocardiography. Journal of the American College of Cardiology 29:5, 985-993
    CrossRef

  99. 99

    G KLEIKAMP, H POSIVAL, K MINAMI, A ELBANAYOSY, R KORFER. (1997) Ischemic cardiomyopathy ? revascularization vs. transplantation. European Journal of Cardio-Thoracic Surgery 11, S1-S4
    CrossRef

  100. 100

    Mario F Meza, Marc A Kates, R.Wayne Barbee, Susan Revall, Bret Perry, Joseph P Murgo, Jorge Cheirif. (1997) Combination of Dobutamine and Myocardial Contrast Echocardiography to Differentiate Postischemic From Infarcted Myocardium. Journal of the American College of Cardiology 29:5, 974-984
    CrossRef

  101. 101

    Quintilio Caretta, Paolo Voci, Maria Cristina Acconcia, Flavia Chiarotti. (1997) Collateral flow prevents unintentional myocardial ischemia during antegrade cardioplegia in patients undergoing coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 113:3, 585-593
    CrossRef

  102. 102

    Jan J Piek, Rob A.M van Liebergen, Karel T Koch, Ron J.G Peters, George K David. (1997) Clinical, Angiographic and Hemodynamic Predictors of Recruitable Collateral Flow Assessed During Balloon Angioplasty Coronary Occlusion. Journal of the American College of Cardiology 29:2, 275-282
    CrossRef

  103. 103

    R. Leischik, J. Rose, G. Caspari, A. Skyschally, G. Heusch, R. Erbel. (1997) Contrast echocardiography for assessment of myocardial perfusion. Herz 22:1, 40-50
    CrossRef

  104. 104

    Christian Firschke, Jonathan R Lindner, Norman C Goodman, Danny M Skyba, Kevin Wei, Sanjiv Kaul. (1997) Myocardial Contrast Echocardiography in Acute Myocardial Infarction Using Aortic Root Injections of Microbubbles in Conjunction With Harmonic Imaging: Potential Application in the Cardiac Catheterization Laboratory. Journal of the American College of Cardiology 29:1, 207-216
    CrossRef

  105. 105

    Danny M. Skyba, Gustavo Camarano, Norman C. Goodman, Richard J. Price, Thomas C. Skalak, Sanjiv Kaul. (1996) Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. Journal of the American College of Cardiology 28:5, 1292-1300
    CrossRef

  106. 106

    D POREMBKA. (1996) TRANSESOPHAGEAL ECHOCARDIOGRAPHY. Critical Care Clinics 12:4, 875-918
    CrossRef

  107. 107

    Imran Afridi, Michael L. Main, Paul A. Grayburn. (1996) Accuracy of dobutamine echocardiography for detection of myocardial viability in patients with an occluded left anterior descending coronary artery. Journal of the American College of Cardiology 28:2, 455-459
    CrossRef

  108. 108

    William F. Armstrong. (1996) “Hibernating” myocardium: Asleep or part dead?. Journal of the American College of Cardiology 28:2, 530-535
    CrossRef

  109. 109

    Yoshihisa Kinoshita, Atsuko Suzuki, Tohru Nakajima, Yasuo Ono, Yoshio Arakaki, Tetsuro Kamiya. (1996) Collateral vessels assessed by myocardial contrast echocardiography in patients with coronary artery lesions after Kawasaki disease. Heart and Vessels 11:4, 203-210
    CrossRef

  110. 110

    S ARONSON. (1996) STRESS ECHOCARDIOGRAPHY, CONTRAST ECHOCARDIOGRAPHY, AND TISSUE CHARACTERIZATIONApplications for the Future. Critical Care Clinics 12:2, 429-450
    CrossRef

  111. 111

    Meredith L.K. Sheil, Sanjiv Kaul, William D. Spotnitz. (1996) Myocardial contrast echocardiography: Development, applications, and future directions. Academic Radiology 3:3, 260-275
    CrossRef

  112. 112

    Freek W.A. Verheugt, Albert Meijer, Wim K. Lagrand, Machiel J. van Eenige. (1996) Reocclusion: The flip side of coronary thrombolysis. Journal of the American College of Cardiology 27:4, 766-773
    CrossRef

  113. 113

    L. Candelise, C. Roncaglioni, E. Aritzu, A. Ciccone, A. P. Maggioni, . (1996) Thrombolytic therapy. From myocardial to cerebral infarction. The Italian Journal of Neurological Sciences 17:1, 5-21
    CrossRef

  114. 114

    P GRAYBURN. (1995) How good is echocardiography at assessing myocardial viability?. The American Journal of Cardiology 76:16, 1183-1184
    CrossRef

  115. 115

    Christiane E. Angermann, Thomas M. Krüger, Reinhard Junge, Ralph Drewello, Hans Ulrich Stempfle, Christoph H. Spes, Karl Theisen. (1995) Intravenous Albunex during transesophageal echocardiography: Quantitative assessment by videodensitometry and integrated backscatter analysis from unprocessed radiofrequency signals. Journal of the American Society of Echocardiography 8:6, 839-853
    CrossRef

  116. 116

    Paul A. Grayburn, John M. Erickson, Jose Escobar, Leeann Womack, Carlos E. Velasco. (1995) Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemia. Journal of the American College of Cardiology 26:5, 1340-1347
    CrossRef

  117. 117

    Marc A. Brouwer, Jan R. Böhncke, Gerrit Veen, Albert Meijer, Machiel J. van Eenige, Freek W.A. Verheugt. (1995) Adverse long-term effects of reocclusion after coronary thrombolysis. Journal of the American College of Cardiology 26:6, 1440-1444
    CrossRef

  118. 118

    Knud Landmark, Michael Abdelnoor, Petter Urdal. (1995) Infarct size estimated from peak creatine kinase is reduced in patients using beta-blockers at the onset of chest pain. Pharmacoepidemiology & Drug Safety 4:5, 269-274
    CrossRef

  119. 119

    David S. Bach, William F. Armstrong, Tyrone Collins, David W.M. Muller, Steven R. Ramee, Denise E. Bruns, Jorge Cheirif. (1995) Intracoronary and aortic root myocardial contrast echocardiography: The effect of route, dose, and pharmacologic coronary vasodilation. Journal of the American Society of Echocardiography 8:5, 719-727
    CrossRef

  120. 120

    Jorge B. Cheirif, Joanna B. Narkiewicz-Jodko, Hal K. Hawkins, Joseph S. Bravenec, Miguel A. Quinones, Judith K. Mickelson. (1995) Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronary thrombosis and reperfusion. Journal of the American College of Cardiology 26:2, 537-546
    CrossRef

  121. 121

    Howard C. Dittrich, Gary L. Bales, Teri Kuvelas, Roberta M. Hunt, Britta A. McFerran, Yigal Greener. (1995) Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent. Journal of the American Society of Echocardiography 8:4, 465-474
    CrossRef

  122. 122

    Daniele Rovai, Anthony N. DeMaria, Antonio L'Abbate. (1995) Myocardial contrast echo effect: The dilemma of coronary blood flow and volume. Journal of the American College of Cardiology 26:1, 12-17
    CrossRef

  123. 123

    Joseph A. Puma, Michael H. Sketch, James E. Tcheng, Robert A. Harrington, Harry R. Phillips, Richard S. Stack, Robert M. Califf. (1995) Percutaneous revascularization of chronic coronary occlusions: An overview. Journal of the American College of Cardiology 26:1, 1-11
    CrossRef

  124. 124

    JONATHAN LEOR, ROBERT A. KLONER. (1995) Basic View on the Pathobiology of Myocardial Ischemia During Coronary Angioplasty: Implications for Cardiac Protection. Journal of Interventional Cardiology 8:3, 291-299
    CrossRef

  125. 125

    Claudio Marcassa, Michele Galli, Pier Luigi Temporelli, Riccardo Campini, Pedro Silva Orrego, Orazio Zoccarato, Amerigo Giordano, Pantaleo Giannuzzi. (1995) Technetium-99m sestamibi tomographic evaluation of residual ischemia after anterior myocardial infarction. Journal of the American College of Cardiology 25:3, 590-596
    CrossRef

  126. 126

    Masaharu Ishihara, Hikaru Sato, Hironobu Tateishi, Takuji Kawagoe, Yuji Shimatani, Atsushi Ueda, Satoshi Kurisu. (1995) Usefulness of coronary wedge pressure in evaluating coronary collateral circulation in anterior wall acute myocardial infarction. The American Journal of Cardiology 75:5-6, 394-396
    CrossRef

  127. 127

    Luciano Agati, Paolo Voci, Federico Bilotta, Roberto Luongo, Camillo Autore, Maria Penco, Carlo Iacoboni, Francesco Fedele, Armando Dagianti. (1994) Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: A myocardial contrast echocardiographic study. Journal of the American College of Cardiology 24:2, 336-342
    CrossRef

  128. 128

    LEONAKDA GALIUTO, ALFREDO MARCHESE, DANIELA CAVALLARI, SABINO ILICETO, PAOLO RIZZON. (1994) Evaluation of Postinfarction Viable Myocardium at Jeopardy by Dobutamine Echocardiography and Myocardial Contrast Echocardiography. Echocardiography 11:4, 337-342
    CrossRef

  129. 129

    ANANDA R. JAYAWEERA, JIRI SKLENAR, SANJIV KAUL. (1994) Quantification of Images Obtained During Myocardial Contrast Echocardiography. Echocardiography 11:4, 385-396
    CrossRef

  130. 130

    Marcelo Di Carli, Todd Sherman, Sandeep Khanna, Michael Davidson, Soleyman Rokhsar, Randall Hawkins, Michael Phelps, Heinrich Schelbert, Jamshid Maddahi. (1994) Myocardial viability in asynergic regions subtended by occluded coronary arteries: Relation to the status of collateral flow in patients with chronic coronary artery disease. Journal of the American College of Cardiology 23:4, 860-868
    CrossRef

  131. 131

    Bodh I. Jugdutt. (1994) Use of nitroglycerin for the treatment of acute myocardial infarction. Heart and Vessels 9:1, 3-13
    CrossRef

  132. 132

    STEVEN L. SCHWARTZ, BRENDA S. KUSAY, NATESA G. PANDIAN, MARK ARONOVITZ, MARVIN A. KONSTAM, DEEB N. SALEM. (1994) Utility of In Vivo, Intracardiac Two-Dimensional Echocardiography in the Assessment of Myocardial Risk Area and Myocardial Dyssynergy During Coronary Occlusion and Reperfusion. Echocardiography 11:1, 71-78
    CrossRef

  133. 133

    Gerald C. Timmis. (1993) Interventional Cardiology: A Comprehensive Bibliography. Journal of Interventional Cardiology 6:3, 241-269
    CrossRef

  134. 134

    (1993) Collateral Blood Flow and Myocardial Viability. New England Journal of Medicine 328:21, 1570-1570
    Full Text

  135. 135

    Stefan M. Nidorf, Samuel C. Siu, Gabe Galambos, Arthur E. Weyman, Michael H. Picard. (1993) Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. Journal of the American College of Cardiology 21:3, 683-691
    CrossRef

  136. 136

    Donald L. Johnston, Vinod K. Gupta, Richard E. Wendt, John J. Mahmarian, Mario S. Verani. (1993) Detection of viable myocardium in segments with fixed defects on thallium-201 scintigraphy: Usefulness of magnetic resonance imaging early after acute myocardial infarction. Magnetic Resonance Imaging 11:7, 949-956
    CrossRef